Tower Research Capital LLC (Trc) Nkarta, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Nkarta, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 7,071 shares of NKTX stock, worth $14,495. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,071
Previous 4,415
60.16%
Holding current value
$14,495
Previous $19,000
10.53%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding NKTX
# of Institutions
120Shares Held
61.3MCall Options Held
17.6KPut Options Held
1.11M-
Ra Capital Management, L.P. Boston, MA10.8MShares$22.2 Million0.44% of portfolio
-
Black Rock Inc. New York, NY4.06MShares$8.32 Million0.0% of portfolio
-
Samsara Bio Capital, LLC Palo Alto, CA3.77MShares$7.72 Million2.88% of portfolio
-
Nea Management Company, LLC Timonium, MD3.57MShares$7.32 Million0.63% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il3.56MShares$7.31 Million0.0% of portfolio
About Nkarta, Inc.
- Ticker NKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,656,800
- Market Cap $99.7M
- Description
- Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...